Dr Leonard Post takes position on Viralytics board
This article was originally published in Scrip
Executive Summary
Eminent US virologist Dr Leonard Post has joined the board of directors of Viralytics, an Australian biotech company, as a non-executive director. Dr Post was previously a director and consultant of Biovex, which was recently acquired by Amgen, as well as chief scientific officer of LEAD Therapeutics. He is currently CSO of BioMarin Pharmaceuticals, and also an advisor to CM Capital, a director of two US-based biotech companies and a member of several scientific advisory boards.